Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
635.00    -13.00 (-2.01%)
Bid:
635.00
Ask:
637.00
Spread: 2.00 (0.315%)
Market Cap: £704.70m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

Directorate change

15 Jan 2026 07:00

RNS Number : 9490O
Barr(A.G.) PLC
15 January 2026
 

 

15 January 2026

A.G. BARR p.l.c.

("A.G. BARR" or "the Company")

Directorate Change

A.G. BARR, the multi-beverage business with a portfolio of market-leading UK brands including IRN-BRU, Rubicon, Boost and FUNKIN, announces that Mark Allen OBE is standing down from his roles as Non-Executive Chair and Director of A.G. BARR as of today to focus on his recently extended role at Hilton Food Group plc, where he has moved from Non-Executive Chair to Executive Chair.

The Board has initiated an independent process to identify a new Non-Executive Chair. Susan Barratt, Senior Independent Director, will act as Interim Chair until a successor has been appointed. Louise Smalley, Non-Executive Director, will serve as Senior Independent Director during this interim period.

Mark Allen OBE, Non-Executive Chair, said:

"It's been an enormous privilege serving as Chair of AG Barr as the Company has strengthened and innovated its brand portfolio, driven value-creating M&A, and delivered value for shareholders. The business is in great shape and now is the right time to pass on the baton and focus on my other commitments."

Susan Barratt, Senior Independent Director, said:

"On behalf of the Board, I would like to express our gratitude to Mark for his outstanding contribution and dedicated service to AG Barr over the last five years. He has built and led a high-quality Board and advanced the strategic direction for the business. He leaves AG Barr in a strong position, and we wish him all the best for the future."

The Company looks forward to providing a Trading Update for the financial year ended 31 January 2026 on 3 February 2026, ahead of announcing Final Results in March 2026.

 

A.G. BARR 0330 390 3900

Euan Sutherland, Chief Executive Officer

Stuart Lorimer, Chief Finance and Operating Officer

Ewan Dytch, Corporate Finance Director

investorrelations@agbarr.co.uk

 

MHP Group 07801 894 577

Oliver Hughes

Rachel Farrington

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAAKQBNOBKDODD
Date   Source Headline
9th Apr 202511:23 amRNSDirector/PDMR Shareholding
8th Apr 20253:29 pmRNSDirector/PDMR Shareholding
25th Mar 20257:00 amRNSResults for year ended 25 January 2025
10th Mar 20252:04 pmRNSDirector/PDMR Shareholding
10th Feb 20253:59 pmRNSDirector/PDMR Shareholding - Replacement
10th Feb 20253:10 pmRNSDirector/PDMR Shareholding
28th Jan 20257:00 amRNSTrading Update
20th Jan 202511:00 amRNSDirector Declaration
9th Jan 20254:42 pmRNSDirector/PDMR Shareholding
7th Jan 202511:44 amRNSNotice of Trading Update
17th Dec 20249:20 amRNSDirector Declaration
9th Dec 20241:50 pmRNSDirector/PDMR Shareholding
12th Nov 20241:35 pmRNSDirector/PDMR Shareholding
4th Nov 202410:54 amRNSDirector/PDMR Shareholding
9th Oct 202410:10 amRNSDirector/PDMR Shareholding
24th Sep 20247:00 amRNSInterim Results
9th Sep 20241:03 pmRNSDirector/PDMR Shareholding
4th Sep 20249:08 amRNSDirector Declaration
20th Aug 20248:39 amRNSDirector/PDMR Shareholding
8th Aug 20241:10 pmRNSDirector/PDMR Shareholding
30th Jul 20247:00 amRNSTrading Statement
8th Jul 202412:03 pmRNSDirector/PDMR Shareholding
4th Jul 202410:17 amRNSNotice of Results
1st Jul 20244:50 pmRNSDirector/PDMR Shareholding
21st Jun 20243:22 pmRNSDirector/PDMR Shareholding
10th Jun 20241:51 pmRNSDirector/PDMR Shareholding
10th Jun 20241:48 pmRNSDirector/PDMR Shareholding
4th Jun 20249:36 amRNSDirector/PDMR Shareholding
31st May 20241:54 pmRNSResult of AGM
9th May 202411:28 amRNSDirector/PDMR Shareholding
7th May 20249:06 amRNSDirector/PDMR Shareholding
23rd Apr 20249:17 amRNSAnnual Financial Report
15th Apr 20242:59 pmRNSDirector/PDMR Shareholding
9th Apr 20243:46 pmRNSDirector/PDMR Shareholding - replacement
9th Apr 20243:36 pmRNSDirector/PDMR Shareholding
9th Apr 20241:05 pmRNSDirector/PDMR Shareholding - replacement
9th Apr 202412:50 pmRNSDirector/PDMR Shareholding
5th Apr 20242:26 pmRNSDirector/PDMR Shareholding
2nd Apr 202411:15 amRNSDirector/PDMR Shareholding
28th Mar 202410:10 amRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSDirectorate changes announcement
26th Mar 20247:00 amRNSFinal Results
14th Mar 20243:01 pmRNSBusiness reorganisation
11th Mar 20248:39 amRNSDirector/PDMR Shareholding
27th Feb 20241:47 pmRNSHolding(s) in Company
8th Feb 20242:03 pmRNSDirector/PDMR Shareholding - Replacement
8th Feb 20241:51 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBoard succession announcement
1st Feb 20247:00 amRNSTrading Update
16th Jan 20247:00 amRNSNotice of Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.